HFS
RPRX icon

Hantz Financial Services’s Royalty Pharma RPRX Stock Holding History

Hantz Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Hold
233
– – ﹤0.01% 2041
2026
Q1 		$11K Hold
233
– – ﹤0.01% 2028
2025
Q4 		$9K Hold
233
– – ﹤0.01% 2029
2025
Q3 		$8K Buy
233
+36
+18% +$1.3K ﹤0.01% 1909
2025
Q2 		$7K Buy
+197
New +$6.53K ﹤0.01% 1647

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hantz Financial Services's RPRX Position: Q2 2026 in Review

Hantz Financial Services held its Royalty Pharma (RPRX) position steady in Q2 2026 at 233 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

Hantz Financial Services first reported a position in RPRX in Q2 2025 and has held it in 5 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Hantz Financial Services held 233 shares of Royalty Pharma worth $13K as of Q2 2026.
  • Hantz Financial Services left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2041 holding.
  • Hantz Financial Services first reported a position in Royalty Pharma in Q2 2025 and has held it in 5 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.